BUY Pine Labs Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred 1–3 months)25 Aug 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
6 advisors have active long-term BUY calls on this stock
Advisor consensus · adjacent horizon·30 Jul · 4w ago
Pine Labs Q1 Results: Profit Soars 4x As Margins Expand Sharply; Revenue Up 20%
NewsNdtv-Profit·28 Jul · 4w ago
Pine Labs shares jump over 4% after Q1 profit nearly quadruples, margin improves
NewsCnbc-Tv18·28 Jul · 4w ago
1 other SEBI-registered advisor has an active short-term BUY call on this stock
Advisor consensus · same horizon·10 Jun · 3mo ago
Sensex, Nifty end higher after CAS adjustment: What drove today’s trade?
NewsCnbc-Tv18·10 Aug · 2w ago
Pine Labs Limited announced its Q1 FY27 unaudited financial results. The company reported revenue of ₹737 Cr, a 20% YoY increase, and Profit After Tax grew 4X to ₹20 Cr. The Board Meeting to approve t
NSE · Press Release·28 Jul · 4w ago
Pine Labs Ltd announced the outcome of its Board Meeting held on July 28, 2026. The meeting approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, al
BSE · Company Update·28 Jul · 4w ago
Pine Labs Ltd announced the outcome of its Board Meeting held on July 28, 2026. The meeting approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, al
BSE · Board Meeting·28 Jul · 4w ago
Pine Labs Limited announced its unaudited financial results for the quarter ended June 30, 2026. The board meeting to approve these results was held on July 28, 2026.
NSE · Outcome of Board Meeting·28 Jul · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.